Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

Journal of Clinical and Cellular Immunology : Citations & Metrics Report

Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total published articles	30	31	30	59	28	11	35	56	95	105	101	105	64	15	3
Research, Review articles and Editorials	2	13	8	23	18	8	25	35	54	86	79	35	23	14	3
Research communications, Review communications, Editorial communications, Case reports and Commentary	20	18	22	22	10	3	10	21	39	6	9	7	1	1	0
Conference proceedings	0	16	15	6	0	98	178	206	171	160	195	156	74	0	0
Citations received as per Google Scholar, other indexing platforms and portals	653	826	931	1079	1018	971	871	851	753	550	276	145	43	40	0

Journal total citations count	8361
Journal impact factor	24.12
Journal 5 years impact factor	31.14
Journal cite score	30.45
Journal h-index	42
Journal h-index since 2019	32

Important citations (1511)

pahan k (2013) multiple sclerosis and experimental allergic encephalomyelitis. journal of clinical & cellular immunology 23: 4. View at Publisher View at Google Scholar
arkwright r, pham tm, zonder ja, dou qp (2017) the preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma. exp opi drug disc. View at Publisher View at Google Scholar
mattern mr, eddins mj, agarwal s, sterner de, kodrasov mp, et al. (2014) proteasome inhibitors versus e3 ligase inhibitors for cancer therapy. inresistance to proteasome inhibitors in cancer 291-316. View at Publisher View at Google Scholar
kogelheide f, kartaschew k, strack m, baldus s, metzler-nolte n, et al. (2016) ftir spectroscopy of cysteine as a ready-to-use method for the investigation of plasma-induced chemical modifications of macromolecules. journal of physics d: applied physics 49:084004. View at Publisher View at Google Scholar
su x, yao q, gu z, shen j, wang z, et al. (2016) psmb4 promotes glioma proliferation via nf-κb signaling. int j clin exp med 9: 19164-19174. View at Publisher View at Google Scholar
dwane l, gallagher wm, chonghaile tn, o'connor dp (2017) the emerging role of non-traditional ubiquitination in oncogenic pathways. j biol chem r116. View at Publisher View at Google Scholar
kaur g, batra s (2016) emerging role of immunoproteasomes in pathophysiology. immunol cell bio 94: 812-820. View at Publisher View at Google Scholar
loizidou ez, zeinalipourâ€yazdi cd (2014) computational inhibition studies of the human proteasome by argyrinâ€based analogues with subunit specificity. chem biolo drug des 84: 99-107. View at Publisher View at Google Scholar
yang x, shi z, zhang n, ou z, fu s, et al. (2014) suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells. can cell int 14: 107. View at Publisher View at Google Scholar
Ji xuebin, hou ming (2014) a new approach to t cell immune tolerance induced by primary immune thrombocytopenia. chin j hematol 35: 862-865. View at Publisher View at Google Scholar
Khosroabadi m, ghorbani m, rahmani f, knaup c (2014) neutron capture therapy: a comparison between dose enhancement of various agents, nanoparticles and chemotherapy drugs. aust phy eng sci med 37: 541-549. View at Publisher View at Google Scholar
travers ts, harlow l, rosas io, gochuico br, mikuls tr, et al. extensive citrullination promotes immunogenicity of hsp90 through protein unfolding and exposure of cryptic epitopes. the journal of immunology 197:1926-36. View at Publisher View at Google Scholar
Liu r, lu s, deng y, yang s, he s, et al. (2016) psmb4 expression associates with epithelial ovarian cancer growth and poor prognosis. arch gynecol obst 293: 1297-1307. View at Publisher View at Google Scholar
Amita m, takahashi t, igarashi h, nagase s (2016) clomiphene citrate down-regulates estrogen receptor-Î± through the ubiquitin-proteasome pathway in a human endometrial cancer cell line. mol cell endocrinol 428: 142-147. View at Publisher View at Google Scholar
huang z, peng s, knoff j, lee sy, yang b, et al. (2015) combination of proteasome and hdac inhibitor enhances hpv16 e7-specific cd8+ t cell immune response and antitumor effects in a preclinical cervical cancer model. j biome sci 22: 7. View at Publisher View at Google Scholar
Patriquin cj, thomas mr, dutt t, mcguckin s, blombery pa, et al. (2016) bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura. brit j haematol 173: 779-7s85. View at Publisher View at Google Scholar
Nicholson b, kumar s, agarwal s, eddins m, marblestone jg, et al. (2014) discovery of therapeutic deubiquitylase effector molecules current perspectives. j biomol scr. View at Publisher View at Google Scholar
lazarus rc, buonora je, flora mn, freedy jg, holstein gr, et al.(2015) protein citrullination: a proposed mechanism for pathology in traumatic brain injury. frontiers in neurology. View at Publisher View at Google Scholar
StÄƒnciulescu ec, pisoschi cg, rÄƒu g, andrei am, baniÈ›Äƒ m (2014) proteasome inhibition: recent advances in antitumoral therapy.farmacia 62: 2. View at Publisher View at Google Scholar
Zheng p, guo h, li g, han s, luo f, et al. (2015) psmb4 promotes multiple myeloma cell growth by activating nf-Îºb-mir-21 signaling. biochem biophys res com 458: 328-333. View at Publisher View at Google Scholar
Prev 1 2 ... 46 47 48 49 50 51 52 53 54 55 56 ... 75 76 Next »

Top